Panx3

Pannexin-3

Spatial tier: STRICT_EXCLUSIVE · Class: ION_CHANNEL · Top region: PVT (Paraventricular nucleus of the thalamus) · Positive regions: 7/554

50.9Discovery Score
39.3Targetability Score
CEvidence grade C
What this means: Panx3: predicted fine-region profile is strict-exclusive, with 7 positive regions out of 554 (limit 12); direct spatial validation is required.

Function in PVT: evidence, prediction, innovation

Gene function
Panx3 encodes pannexin-3, a large-pore channel acting as an ER Ca2+ leak channel, ATP-releasing hemichannel and gap junction. It drives osteoblast and chondrocyte differentiation via Wnt and p21; unlike Panx1 it is largely absent from neural tissue, documented in skin, cartilage, bone and cochlea.
Region function
The paraventricular thalamus is a midline glutamatergic hub relaying hypothalamic and brainstem state signals to accumbens, amygdala and cortex, required for wakefulness, salience, stress and anxiety.
Published in this region
inferred No region-specific literature found. The closest finding is Penuela et al. 2007, who detected Panx1 in brain while Panx3 was confined to skin and cartilage, whereas PVT cell-type surveys describe neuropeptide-defined populations without mentioning pannexins (Curtis et al. 2020).
Predicted function
Prediction: Panx3 most likely acts as an ATP-release hemichannel or ER Ca2+ leak pathway in PVT glutamatergic neurons or astrocytes. Since PVT ATP/adenosine tone tracks arousal, conditional PVT deletion should fragment wake bouts and alter NREM delta rebound, and hemichannel block should dampen stress-evoked PVT c-Fos. Vascular and ependymal cells must be excluded first.
Innovation
★★★★★ 5/5 Pannexin-3 has essentially no neuroscience literature, so a neuronal or glial role in this thalamic nucleus would be first in field.
Tools
Global and conditional Panx3 knockouts exist from bone and skin work; Panx3 antibodies (Laird group); pharmacology is non-selective (probenecid, carbenoxolone; 10Panx targets Panx1). PVT is accessible with Vglut2-Cre, Drd2-Cre, Gal-Cre.
References

Direct evidence located at the region

Panx3 Allen ISH at the CCF centroid of PVT

Allen ISH experiment 68668114, section image 68352452 (section 130): the section that contains the CCF centroid of Paraventricular nucleus of the thalamus according to the Allen image-to-atlas alignment (reference_to_image), with a 2 mm window around that point. Left: whole section, red box = window. Middle: ISH signal. Right: Allen's expression-mask view of the same window. open this image in the Allen viewer

Direct spatial evidence

MERFISH REGION LOCATOR
PVT MERFISH region locator
Real single-cell MERFISH coordinates for the PVT (Paraventricular nucleus of the thalamus) section -- our own ground-truth data, showing exactly where this region sits, independent of whether the Allen ISH section below is easy to read.
DIRECT ALLEN ISH
Allen ISH experiment 68668114, image 68352412 -- target region: PVT (Paraventricular nucleus of the thalamus)
Allen ISH experiment 68668114, image 68352412 -- target region: PVT (Paraventricular nucleus of the thalamus)
DIRECT ALLEN ISH
Allen ISH experiment 68668114, image 68352414 -- target region: PVT (Paraventricular nucleus of the thalamus)
Allen ISH experiment 68668114, image 68352414 -- target region: PVT (Paraventricular nucleus of the thalamus)

Regional expression figure

Panx3 regional expression profile

Predicted WMB × fine-CCF profile; not direct full-transcriptome spatial measurement.

Spatial profile

PVT
0.127
PBG
0.0774
CM
0.0669
PT
0.0421
IA
0.0326
BMAa
0.0313
IMD
0.0306
MD
0.0288
IAM
0.0271
CUN
0.0232
PP
0.0186
ICd
0.017
SPA
0.0159
Xi
0.0159
COAa
0.0157
PIL
0.0153
AD
0.0152
SPFm
0.0143
SPFp
0.0126
SCdw
0.0124

Evidence and specificity

Evidence status
PREDICTED_FINE
Direct sources
None; predicted localization only
Exclusive threshold
12 positive regions out of 554
Spatial specificity
0.423
Top-region fraction
0.174
Filter status
PASS

Interpretation limits